Topics

Servier gains non-Hodgkin lymphoma drug from CTI BioPharma http://bit.ly/350WmN2 

14:45 EDT 3 Oct 2019 | Pharmafile

Servier gains non-Hodgkin lymphoma drug from CTI BioPharma http://bit.ly/350WmN2 

Original Article: Servier gains non-Hodgkin lymphoma drug from CTI BioPharma http://bit.ly/350WmN2 

NEXT ARTICLE

More From BioPortfolio on "Servier gains non-Hodgkin lymphoma drug from CTI BioPharma http://bit.ly/350WmN2 "

Quick Search

Relevant Topics

Hodgkin lymphoma
Hodgkin Lymphoma is a  disorder caused by malignant proliferation of lymphocytes, which contain characteristic mirror-image nuclei (Reed-Sternburg cells). The resulting lymphadenopathy can be limited to a single lymph node region (Stage 1) or spread...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...